Norway’s Crown Princess Mette-Marit has undergone a lung transplant after a serious decline in her health linked to a long-term respiratory condition, the Royal Palace has confirmed.
The operation was carried out at Oslo University Hospital after doctors determined that her pulmonary fibrosis had worsened significantly, making a transplant the only viable treatment option at this stage.
Pulmonary fibrosis is a chronic lung disease that causes progressive scarring of lung tissue, making it increasingly difficult for patients to breathe and carry out daily activities.
The Royal Palace said the surgery was successful and that the Crown Princess is now in a stable condition, although she will remain under close medical observation during the early stages of recovery.
Doctors are expected to monitor her closely for signs of improvement while also managing possible post-transplant complications, which are common in the first weeks after such procedures.
Her condition had reportedly deteriorated over time, leading to her placement on the national transplant waiting list as her breathing difficulties became more severe.
The Norwegian Royal Family has expressed appreciation for public support, describing the period as a challenging time for both the Princess and her family.
Crown Prince Haakon is expected to temporarily adjust his royal duties to remain close to his wife as she undergoes rehabilitation and post-surgery care.
Medical experts note that lung transplant recovery is a long process that requires strict medication routines, regular hospital visits and careful lifestyle adjustments to avoid rejection of the new organ.
As she begins recovery, attention remains focused on her progress, with hopes that the transplant will significantly improve her quality of life in the months ahead.